Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A systematic review of cannabidiol dosing in clinical populations
Sophie Millar, Nicole L. Stone, Z.D. Bellman, et al.
British Journal of Clinical Pharmacology (2019) Vol. 85, Iss. 9, pp. 1888-1900
Open Access | Times Cited: 197

Showing 1-25 of 197 citing articles:

Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
Jerome Sarris, Justin Sinclair, Diana Karamacoska, et al.
BMC Psychiatry (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 201
Towards Better Delivery of Cannabidiol (CBD)
Sophie Millar, Ryan Maguire, Andrew Yates, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 9, pp. 219-219
Open Access | Times Cited: 172
Dosage, Efficacy and Safety of Cannabidiol Administration in Adults: A Systematic Review of Human Trials
Christian Larsen, Jorida Shahinas
Journal of Clinical Medicine Research (2020) Vol. 12, Iss. 3, pp. 129-141
Open Access | Times Cited: 148
Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems
Julie Moltke, Chandni Hindocha
Journal of Cannabis Research (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 109
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial
Peter Grimison, Antony Mersiades, Adrienne Kirby, et al.
Annals of Oncology (2020) Vol. 31, Iss. 11, pp. 1553-1560
Open Access | Times Cited: 118
The potential of cannabidiol in the COVID‐19 pandemic
Giuseppe Esposito, Marcella Pesce, Luisa Seguella, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 21, pp. 4967-4970
Open Access | Times Cited: 108
Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
Patrícia Alves, Cristina Amaral, Natércia Teixeira, et al.
Pharmacological Research (2020) Vol. 157, pp. 104822-104822
Closed Access | Times Cited: 106
Neurocognitive consequences of chronic cannabis use: a systematic review and meta-analysis
Pedro Rafael Figueiredo, Serenella Tolomeo, J. Douglas Steele, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 108, pp. 358-369
Open Access | Times Cited: 102
Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts
Torsten Lowin, Ren Tingting, Julia Zurmahr, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 8
Open Access | Times Cited: 102
Cannabinoids Exacerbate Alcohol Teratogenesis by a CB1-Hedgehog Interaction
Eric W. Fish, Laura B. Murdaugh, Chengjin Zhang, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 98
Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease
Felipe Patricio, Alan Axel Morales-Andrade, Aleidy Patricio-Martínez, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 96
Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches
Vinit Raj, Jae Gyu Park, Kiu-Hyung Cho, et al.
International Journal of Biological Macromolecules (2020) Vol. 168, pp. 474-485
Open Access | Times Cited: 95
A systematic review of minor phytocannabinoids with promising neuroprotective potential
Nicole L. Stone, Alexandra J. Murphy, Timothy J. England, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 19, pp. 4330-4352
Open Access | Times Cited: 85
Use and Perceptions of Cannabidiol Products in Canada and in the United States
Samantha Goodman, Elle Wadsworth, Gillian L. Schauer, et al.
Cannabis and Cannabinoid Research (2020) Vol. 7, Iss. 3, pp. 355-364
Open Access | Times Cited: 81
Access to cannabidiol without a prescription: A cross-country comparison and analysis
Iain S. McGregor, Elizabeth A. Cairns, Sarah V. Abelev, et al.
International Journal of Drug Policy (2020) Vol. 85, pp. 102935-102935
Open Access | Times Cited: 80
Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic
Lucile Rapin, Rihab Gamaoun, Cynthia El Hage, et al.
Journal of Cannabis Research (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 66
Cytochrome P450–Catalyzed Metabolism of Cannabidiol to the Active Metabolite 7-Hydroxy-Cannabidiol
Jessica L. Beers, Dong Fu, Klarissa D. Jackson
Drug Metabolism and Disposition (2021) Vol. 49, Iss. 10, pp. 882-891
Open Access | Times Cited: 60
The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence
Jonathon C. Arnold, Danielle McCartney, Anastasia Suraev, et al.
Clinical and Translational Science (2022) Vol. 16, Iss. 1, pp. 10-30
Open Access | Times Cited: 54
Cannabidiol activates neuronal Kv7 channels
Han-Xiong Bear Zhang, Laurel M. Heckman, Zachary Niday, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 40
Impacts of medical and non-medical cannabis on the health of older adults: Findings from a scoping review of the literature
Dianna Wolfe, Kim Corace, Claire Butler, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0281826-e0281826
Open Access | Times Cited: 30
Differential regulation of Cav3.2 and Cav2.2 calcium channels by CB1 receptors and cannabidiol
Erika K. Harding, Ivana A. Souza, María A. Gandini, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 12, pp. 1616-1633
Open Access | Times Cited: 25
Cannabidiol - a friend or a foe?
Bianca-Maria Tihăuan, Tatiana Onisei, Walter Slootweg, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107036-107036
Open Access | Times Cited: 1
Predicting the Potential for Cannabinoids to Precipitate Pharmacokinetic Drug Interactions via Reversible Inhibition or Inactivation of Major Cytochromes P450
Sumit Bansal, Neha Maharao, Mary F. Paine, et al.
Drug Metabolism and Disposition (2020) Vol. 48, Iss. 10, pp. 1008-1017
Open Access | Times Cited: 67
A Balanced Approach for Cannabidiol Use in Chronic Pain
Donovan A. Argueta, Christopher Ventura, Stacy Kiven, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 60
Page 1 - Next Page

Scroll to top